Showing results (221-230 of 336) with videos related to
Sort By:
Pageof 34
Biochemical Pharmacology|December 15, 2022
Upregulation of PIK3IP1 monitors the anti-cancer activity of PI3Kα inhibitors in gastric cancer cellsXu-Bin Ma, Yang Wang, Ying-Jie Jia, et al.Journal of Medicinal Chemistry|January 12, 2024
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer TherapyLiang Shen, Bo Wang, Shao-Peng Wang, et al.Frontiers in Oncology|April 12, 2021
Jiyuan Oridonin A Overcomes Differentiation Blockade in Acute Myeloid Leukemia Cells With MLL Rearrangements via Multiple Signaling PathwaysMei Qu, Yu Duan, Min Zhao, et al.Bioorganic & Medicinal Chemistry Letters|July 9, 2014
Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agentsKun-Peng Shao, Xu-Yao Zhang, Peng-Ju Chen, et al.European Journal of Medicinal Chemistry|November 12, 2022
New drug approvals for 2021: Synthesis and clinical applicationsShuo Yuan, Dan-Shu Wang, Hui Liu, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 1, 2014
Determination and pharmacokinetic study of the novel anti-tumor candidate drug DG-7 in rat plasma by liquid chromatography-tandem mass spectrometryJuan Li, Dan-Dan Liu, Yu Ke, et al.European Journal of Medicinal Chemistry|November 3, 2018
Novel 3-(2,6,9-trisubstituted-9H-purine)-8-chalcone derivatives as potent anti-gastric cancer agents: Design, synthesis and structural optimizationTao-Qian Zhao, Yuan-Di Zhao, Xin-Yang Liu, et al.Toxicology and Applied Pharmacology|December 3, 2014
Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM-Chk1/2-Cdc25C pathwayYong-Cheng Ma, Nan Su, Xiao-Jing Shi, et al.Bioorganic & Medicinal Chemistry Letters|January 23, 2014
Synthesis and antimicrobial activities of novel 1,2,4-triazolo [3,4-a] phthalazine derivativesQiu-Rong Zhang, Deng-Qi Xue, Peng He, et al.European Journal of Medicinal Chemistry|March 13, 2023
Discovery of acridine-based LSD1 inhibitors as immune activators targeting LSD1 in gastric cancerHui-Min Liu, Xiao-Peng Xiong, Jiang-Wan Wu, et al.Pageof 34